John Francis Assini, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1270 Belmont Ave, Suite 380, Schenectady, NY 12308 Phone: 518-386-3626 Fax: 518-386-3612 |
Dr. Donald Wexler, Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 600 Mcclellan St, Schenectady, NY 12304 Phone: 518-347-5505 Fax: 518-347-5504 |
News Archive
A team of international scientists recently conducted an open-level clinical trial to investigate the effects of personalized immunotherapy on critically ill COVID-19 patients.
Falls and fall prevention are a major concern for the elderly and people with osteoporosis, a common chronic disease which causes weak and fragile bones. People with osteoporosis are at increased risk of fracture, even after a minor fall from standing height.
A major factor underlying Parkinson's Disease pathology is the loss of dopamine neurons in the substantia nigra, and thus current therapies often aim to restore dopamine signaling. However, these treatments are not curative.
Trimel Pharmaceuticals Corporation (TSX: TRL) announced today top-line results of its Phase II clinical trial evaluating the efficacy and safety of Tefina™, a "use-as-required" testosterone nasal gel for the treatment of Female Orgasmic Disorder (FOD).
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, announces today an exclusive partnership agreement with Therabel Group for the European commercialization rights of Loramyc® and Setofilm® including France and the associated French commercial structure to a newly established entity, Therabel Hôpital Pharma.
› Verified 6 days ago